{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:41:38Z","timestamp":1778215298094,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1007\/bf00879659","type":"journal-article","created":{"date-parts":[[2004,12,25]],"date-time":"2004-12-25T17:31:30Z","timestamp":1103995890000},"page":"728-731","source":"Crossref","is-referenced-by-count":8,"title":["Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: Correlation with the effect of a single administration of octreotide on serum TSH levels"],"prefix":"10.1007","volume":"24","author":[{"given":"M.","family":"Losa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Persani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Acerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Giugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Songini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Beck-Peccoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Giovanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000180687","volume":"26","author":"G Faglia","year":"1987","unstructured":"Faglia G, Beck-Peccoz P, Piscitelli G, Medri G. Inappropriate secretion of thyrotropin by the pituitary. Horm Res 1987; 26: 79?99.","journal-title":"Horm Res"},{"key":"CR2","first-page":"139","volume-title":"Pituitary adenomas: biology, diagnosis and treatment","author":"P Beck-Peccoz","year":"1996","unstructured":"Beck-Peccoz P, Persani L. Thyrotropin (TSH)-secreting pituitary tumors: endocrinology, clinical aspects and treatment. In: Landolt AM, Vance ML, Reilly PL, eds.Pituitary adenomas: biology, diagnosis and treatment. London: Churchill Livingstone; 1996: 139?155."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-111-10-827","volume":"111","author":"N Gesundheit","year":"1989","unstructured":"Gesundheit N, Petrick PA, Nissim M, et al. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.Ann Intern Med 1989; 111: 827?835.","journal-title":"Ann Intern Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3171\/jns.1990.73.5.0674","volume":"73","author":"IE McCutcheon","year":"1990","unstructured":"McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyrotropin-secreting pituitary adenomas.J Neurosurg 1990; 73: 674?683.","journal-title":"J Neurosurg"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-8529(18)30473-0","volume":"16","author":"RC Smallridge","year":"1987","unstructured":"Smallridge RC. Thyrotropin-secreting pituitary tumors.Endocrinol Metab Clin North Am 1987; 16: 765?791.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7326\/0003-4819-119-3-199308010-00010","volume":"119","author":"P Chanson","year":"1993","unstructured":"Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid stimulating secreting pituitary adenomas. A follow-up of 52 patients.Ann Intern Med 1993; 119: 236?240.","journal-title":"Ann Intern Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-96-2-251","volume":"96","author":"S Connel","year":"1982","unstructured":"Connel S, McCruden DC, Davies DL, Alexander W. Bromocriptine for inappropriate thyrotropin secretion.Ann Intern Med 1982; 96: 251?252.","journal-title":"Ann Intern Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198707023170103","volume":"317","author":"RJ Comi","year":"1987","unstructured":"Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.N Engl J Med 1987; 317: 12?17.","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb03941.x","volume":"40","author":"A Gancel","year":"1994","unstructured":"Gancel A, Vuillermet P, Legrand A, Cams F, Thomas F, Kuhn JM. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.Clin Endocrinol (Oxf) 1994; 40: 421?428.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jcem-68-1-208","volume":"68","author":"P Beck-Peccoz","year":"1989","unstructured":"Beck-Peccoz P, Mariotti S, Guillausseau J, et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995.J Clin Endocrinol Metab 1989; 68: 208?214.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199011013231805","volume":"323","author":"SWJ Lamberts","year":"1990","unstructured":"Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors.N Engl J Med 1990; 323: 1246?1249.","journal-title":"N Engl J Med"},{"key":"CR12","first-page":"652","volume":"33","author":"EP Krenning","year":"1992","unstructured":"Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]-octreotide in man: metabolism, dosimetry and comparison with [123I-Tyr3]-octreotide.J Nucl Med 1992; 33: 652?658.","journal-title":"J Nucl Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/jcem-71-3-566","volume":"71","author":"SWJ Lamberts","year":"1990","unstructured":"Lamberts SWJ, Hofland LJ, van Koetsveld PM, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization and therapy.J Clin Endocrinol Metab 1990; 71: 566?574.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/jcem-73-4-850","volume":"73","author":"G Faglia","year":"1991","unstructured":"Faglia G, Bazzoni N, Spada A, et al. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).J Clin Endocrinol Metab 1991; 73: 850?856.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR15","first-page":"3084","volume":"81","author":"M Losa","year":"1996","unstructured":"Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.J Clin Endocrinol Metab 1996; 81: 3084?3090.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9343(94)90059-0","volume":"96","author":"WW Herder de","year":"1994","unstructured":"de Herder WW, Krenning EP, Malchoff CD, et al. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.Am J Med 1994; 96: 305?312.","journal-title":"Am J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","volume":"12","author":"SWJ Lamberts","year":"1991","unstructured":"Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the treatment of tumors.Endocr Rev 1991; 12: 450?482.","journal-title":"Endocr Rev"},{"key":"CR18","first-page":"85","volume-title":"Molecular and clinical advances in pituitary disorders","author":"SWJ Lamberts","year":"1990","unstructured":"Lamberts SWJ, Krenning EP, Bakker WH, Breeman WAP, Kooij PPM, Reubi JC. Somatostatin receptor imaging in the diagnosis of pituitary and parasellar tumours. In: Melmed S, Robbins RJ, eds. Molecular and clinical advances in pituitary disorders. Boston: Blackwell Scientific; 1990: 85?292."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00175168","volume":"20","author":"NPLG Verhoeff","year":"1993","unstructured":"Verhoeff NPLG, Bemelman FJ, Wiersinga WM, van Royen EA. Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH\/PRL-producing pituitary macroadenoma.Eur J Nucl Med 1993; 20: 555?561.","journal-title":"Eur J Nucl Med"},{"key":"CR20","first-page":"58","volume":"5","author":"MC Pierantoni","year":"1995","unstructured":"Pierantoni MC, Gasperi M, Molea N, et al. Use of111In-pentetreotide scan in the diagnosis and follow up of pituitary adenomas [abstract].J Endocrinol Invest 1995 Suppl 5: 58.","journal-title":"J Endocrinol Invest"},{"key":"CR21","first-page":"540","volume":"75","author":"J Bertherat","year":"1992","unstructured":"Bertherat J, Brue T, Enjalbert A, et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.J Clin Endocrinol Metab 1992; 75: 540?546.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1210\/jcem-59-6-1148","volume":"59","author":"JC Reubi","year":"1984","unstructured":"Reubi JC, Landolt AM. High density of somatostatin receptors in pituitary tumors from acromegalic patients.J Clin Endocrinol Metab 1984; 59: 1148?1151.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"CR23","first-page":"42","volume":"17","author":"A Colao","year":"1994","unstructured":"Colao A, Lastoria S, Ferone D, et al. Pituitary imaging by labelled indium-111 octreotide (In-111 OCT): a reliable tool to differentiate patients with GH-secreting adenomas responders to chronic treatment [abstract].J Endocrinol Invest 1994; 17 Suppl 2: 42.","journal-title":"J Endocrinol Invest"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00879659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00879659\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00879659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T12:57:50Z","timestamp":1556542670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00879659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["BF00879659"],"URL":"https:\/\/doi.org\/10.1007\/bf00879659","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}